Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
Although drugs have been reported to modulate the gut microbiota, the effects of anti-obesity drugs on the gut microbiota remain unclear. Lorcaserin (LS) and phentermine (PT) are commonly used anti-obesity drugs. However, to our best knowledge, no studies have simultaneously assessed the effects of...
Main Authors: | Eun-Ji Song, Na Rae Shin, Songhee Jeon, Young-Do Nam, Hojun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1109651/full |
Similar Items
-
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
by: Hurt RT, et al.
Published: (2018-09-01) -
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
by: Young Jin Tak, et al.
Published: (2021-04-01) -
Phentermine and Topiramate: Monotherapy and Their Combination Efficacy in the Treatment of Children and Adults with Obesity
by: Ekaterina E. Kopylova, et al.
Published: (2023-12-01) -
A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
by: Kim A, et al.
Published: (2023-08-01) -
Supraventricular tachycardia associated with phentermine use
by: Pakpoom Tantrachoti, et al.
Published: (2016-07-01)